Artelo Biosciences (ARTL) Other Working Capital Changes (2018 - 2020)

Artelo Biosciences (ARTL) has reported Other Working Capital Changes for 7 consecutive years, with -$18000.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Other Working Capital Changes fell 129.51% year-over-year to -$18000.0 in Q4 2025; TTM through Dec 2025 was -$129000.0, a 71.77% increase from a year earlier, with the FY2025 full-year figure at -$129000.0, up 71.77% from the prior year.
• Other Working Capital Changes was -$18000.0 for Q4 2025 at Artelo Biosciences, up from -$53000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $80554.0 in Q1 2021 and troughed at -$478000.0 in Q3 2024.
• A 3-year average of $1117.2 and a median of -$2009.0 in 2019 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes soared 297.16% in 2019 and sank 392.02% in 2020, its largest moves.
• Over 5 years, Other Working Capital Changes stood at -$91000.0 in 2021, then plunged by 79.12% to -$163000.0 in 2022, then surged by 55.21% to -$73000.0 in 2023, then soared by 183.56% to $61000.0 in 2024, then tumbled by 129.51% to -$18000.0 in 2025.
• The last three Other Working Capital Changes figures came in at -$18000.0 (Q4 2025), -$53000.0 (Q3 2025), and -$49000.0 (Q2 2025), per Business Quant data.